Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|October 25, 2022
Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in ratsXin-Mei Li, Yuan-Dong Zheng, Yi-Fan Zhang, et al.
Nature Communications|March 15, 2025
USP7 V517F mutation as a mechanism of inhibitor resistanceYu-Ling Miao, Fengying Fan, Yong-Jun Cheng, et al.
Neoplasia (New York, N.Y.)|July 30, 2022
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapyLi-Na Zhou, Chaodong Xiong, Yong-Jun Cheng, et al.
Biochemical Pharmacology|February 4, 2021
Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1Qian Wu, Dan-Qi Chen, Lin Sun, et al.
European Journal of Medicinal Chemistry|June 18, 2024
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitorsHongrui Li, Ben-Jin Liu, Jiahao Xu, et al.
Pageof 6